Irwin Naturals Signs LOI To Acquire Braxia Scientific Expanding Its Network Of Mental Health Clinics
Irwin Naturals Signs LOI To Acquire Braxia Scientific Expanding Its Network Of Mental Health Clinics
歐文 Naturals 簽署 LI 收購布拉西亞科學擴大其心理健康診所網絡
Irwin Naturals Inc. (OTCQB:IWINF) (CSE:IWIN) (FRA:97X), has entered into a non-binding amended and restated letter of intent for a business combination with Braxia Scientific Corp.(OTCPK:BRAXF) (CSE:BRAX) (FWB:4960), a medical research company providing psychiatric, innovative ketamine and psilocybin treatments for mental health disorders. The LOI sets forth the material terms and conditions upon which Irwin will acquire all of the issued and outstanding common shares of Braxia.
歐文自然公司 (OTCQB: 艾永夫) (CSE: 艾溫) (框架:97X), 已經進入了 非約束力的修訂和重述意向書 對於一個 商務組合 與 布拉西亞科技OTCPK: 布拉克斯) (CSE: BRAX) (FWB: 4960) 是一家提供精神科、創新精神科技的醫學研究公司 氯胺酮和裸蓋菇鹼治療 用於精神健康障礙。LOI 列出了歐文將收購 Braxia 所有已發行和已發行普通股的重要條款和條件。
Under the terms of the LOI, Irwin is prepared to offer a purchase price per Braxia share based upon a valuation of the outstanding Braxia shares of $30 million...
根據 LOI 的條款，歐文準備根據未發行的布拉西亞股票的...
登入免費觀看全文
登入/註冊